Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2014
Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDHJ Gregory Cairncross, Meihua Wang, Robert B Jenkins, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|October 17, 2009
Population-based study of pseudoprogression after chemoradiotherapy in GBMGloria B Roldán, James N Scott, John B McIntyre, et al.
Oncotarget|October 4, 2014
Mutations in CIC and IDH1 cooperatively regulate 2-hydroxyglutarate levels and cell clonogenicitySuganthi Chittaranjan, Susanna Chan, Cindy Yang, et al.
Cancer Research|April 3, 2003
Gene expression-based classification of malignant gliomas correlates better with survival than histological classificationCatherine L Nutt, D R Mani, Rebecca A Betensky, et al.
Nature Communications|May 3, 2019
Capicua regulates neural stem cell proliferation and lineage specification through control of Ets factorsShiekh Tanveer Ahmad, Alexandra D Rogers, Myra J Chen, et al.
The New England Journal of Medicine|March 11, 2005
MGMT gene silencing and benefit from temozolomide in glioblastomaMonika E Hegi, Annie-Claire Diserens, Thierry Gorlia, et al.
Neuro-Oncology|April 15, 2010
Oligodendroglioma cell lines containing t(1;19)(q10;p10)John J P Kelly, Michael D Blough, Owen D M Stechishin, et al.
Neuro-Oncology Advances|November 12, 2021
Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG03.01) randomized clinical trialAndrew J Song, Keyue Ding, Iyad Alnahhas, et al.
Neuro-Oncology Advances|January 31, 2022
Corrigendum to: Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG 08.02) randomized clinical trialAndrew J Song, Keyue Ding, Iyad Alnahhas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 24, 2016
Disulfiram when Combined with Copper Enhances the Therapeutic Effects of Temozolomide for the Treatment of GlioblastomaXueqing Lun, J Connor Wells, Natalie Grinshtein, et al.
Pageof 9